Narrowing racial and ethnic disparities among lung cancer patients

Black Americans have the highest death rate and shortest survival rate of any racial or ethnic group in the U.S. for most cancers, according to a 2019 study. Lung cancer is the second most common [...]

View more

Stereotactic ablative radiation therapy (SABR) for oligometastatic disease

Stereotactic ablative radiation therapy (SABR) is playing an important role in treating oligometastatic patients with breast, lung, colorectal and prostate tumors, according to a review of published literature. With each of these cancers, SABR showed […]

View more

Basel Altoos, M.D., joins Norton Cancer Institute

Basel M. Altoos, M.D., a board-certified radiation oncologist, has joined Norton Cancer Institute and will see patients downtown and at King’s Daughters’ Health in Madison, Indiana. Refer a patient To refer a patient to Norton [...]

View more

Drug targeting prostate cancer cells to deliver radioisotope prolongs survival in trial

A cutting-edge new treatment specifically targets prostate cancer cells to deliver a tumor-killing radioisotope and helped extend patients’ lives longer in an international clinical trial (VISION Study), according to a study published in the New […]

View more

Patient benefits of the Norton Cancer Institute’s multidisciplinary clinics

At Norton Cancer Institute, our goal is to have newly diagnosed cancer patients meet all the potential providers who could be part of their care. With that in mind — and more — we’ve established multidisciplinary […]

View more

HPV and your lesbian patients

Lesbians may be at higher risk for HPV because of historical health care barriers that may have caused reluctance to get preventive screenings. Making matters worse, much of the discussion around sexually transmitted infections (STIs) […]

View more

Screening for lung, colon and breast cancers take priority

After many put off their preventive cancer screenings, Norton Cancer Institute is working to screen as many people as possible as early as possible for lung, colon and breast cancers. Adding urgency to the effort, […]

View more

Access to evolving clinical science close to home

Norton Cancer Institute’s clinical research program was developed to ensure that cancer patients in our community and region have access to evolving clinical science. Guided by an experienced cadre of physicians and supported by a […]

View more

Treating the whole patient at Norton Cancer Institute Women’s Cancer Center

Norton Cancer Institute Women’s Cancer Center has a beautiful new home in Medical Towers South (234 E. Gray St., on the downtown Louisville medical campus) that reflects our goal of treating the whole person. Clinicians […]

View more

Pelvis osteosarcoma study: A complex biplane osteotomy maintains pelvic ring continuity

The patient A 31-year-old otherwise healthy man presented with an enlarging and increasingly symptomatic left posterior ilium tumor. Biopsy revealed high grade osteosarcoma. Additional staging studies demonstrated no distant metastases. He was treated with neoadjuvant […]

View more

Orthopedic oncologist describes multidisciplinary care

Specialists at Norton Orthopedic Institute and Norton Cancer Institute work together in a team approach for treatment of bone and soft tissue tumors. As an orthopedic oncologist, I work closely with medical and radiation oncologists, […]

View more

New lung cancer screening guidelines draw attention to prevalence in Black men

In its March 2021 revised guidelines for lung cancer screening, the U.S. Preventive Services Task Force (USPTF) noted Black men have a higher incidence of lung cancer than white men, and Black women have a […]

View more

Search our entire site.